drugset / Trial / NCT06506565

Low-Dose Ketamine Infusion During Burn Wound Care

NCT06506565 ↗

Phase 4 Recruiting 140 enrolled University of Tennessee
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.

Timeline

Start
2024-07-08
Primary completion
2025-12
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.3 mg/kg —